drugset / Trial / NCT00532688

N-Acetylcysteine in Heart Failure With Coexistent Chronic Renal Failure

NCT00532688

Phase 2/3 Unknown 10 enrolled Bayside Health The Alfred · collab
RandomizedCrossoverQuadruple-blindTreatment

Summary

Treatment with n-acetylcysteine in patients with heart failure and chronic renal failure leads to improvements in vascular function and in renal function.

Timeline

Start
2007-09
Primary completion
Completion
2008-02

Drugs

EvaluationDrugModalityDoseRoute
Subject N-acetylcysteine Small molecule 500 mg Oral